NCT05341726Recruiting
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
BREATHE: An Efficacy-implementation Trial of a Brief Shared Decision Making Intervention Among Black Adults With Uncontrolled Asthma in Federally Qualified Health Centers (Trial and Post-trial)
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the widespread adoption and implementation of BREATHE in FQHCs.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- First submitted
- 18 Apr 2022
- Start date
- 19 Jan 2023
- Primary completion date
- Feb 2028
- Lead sponsor
- Columbia University
- Diseases
- Asthma
- NCT number
- NCT05341726
What you commit to
- Study type: Interventional
- Planned participants: 400
- From 19 Jan 2023 to the primary completion date, Feb 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- serious mental health conditions that preclude completion of study procedures or confound analyses or
- serious mental health conditions that preclude completion of study procedures or confound analyses
Other
- non-English speaking
- participation in a listening session
- Inclusion Criterion (clinicians):
- 1\. those who manage a panel of adult asthma patients
- non-English speaking or
Who the study is looking for
- Patients participants will
- be adults (\> or = 18 years of age)
- self-report race as 'Black' race (African American, African, Caribbean, West Indian, multi-racial \[Black AND one or more additional races\]); identify their ethnicity as Hispanic OR non-Hispanic
- have clinician-diagnosed persistent asthma (defined as being prescribed inhaled corticosteroids in the last 48 months) or have had an asthma exacerbation (e.g., ER visit, course of Prednisone) regardless of controller medicine use
- receive asthma care at a partner FQHC and
- screen positive for uncontrolled asthma as measured by the Asthma Control Questionnaire- 6 items (ACQ-6) and erroneous beliefs as measured by the Conventional and Alternative Management for Asthma (CAM-A) survey.
- must be identified by patient participant as a loved one and
- loved one must be a family member or friend of the patient participant.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sun River Health Coordinator of this site? Confirm its status | Beacon | United States | Recruiting |
| Bedford Stuyvesant Family Health Center Coordinator of this site? Confirm its status | Brooklyn | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.